Repro Med Systems (KRMD) Tops Q3 EPS by 3c, provides guidance

Repro Med Systems (NASDAQ: KRMD) reported Q3 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.68 million.

GUIDANCE:

Repro Med Systems sees FY 2024 revenue of $32.75-33.25 million, versus the consensus of $32.172 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Phillips 66, Marathon Merger Talks Collapsed - Semafor
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c